,

Jianwei Chen1, Wei Wang1, Xubin Hu1

  • 1College of Pharmaceutical Science & Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, China.

PubMed
概括

来自微生物的中型抗菌 (MAP) 由于其稳定性和低耐药性潜力,为传统抗生素提供了有希望的替代品. 本综述探讨了45个MAP,强调了它们的机制和下一代抗生素开发的结构-活性关系.